Carna Biosciences Inc. (4572)
Market Closed
2 Oct, 06:00 AM
JPX JPX Primary ¥
413. 00
-19
-4.3981%
¥
4.36B Market Cap
- P/E Ratio
- Div Yield
96,200 Volume
- Eps
¥ 432
Previous Close Want to track 4572 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Carna Biosciences Inc. (4572) Statistics
Valuation metrics
Market Cap 4.36B
Enterprise value 7.99B
Trailing P/E (ttm) -3.01
Forward P/E 3.86
PEG ratio -1.51
Price/Sales (ttm) 9.75
Price/Book (mrq) -16.47
Enterprise Value/Revenue 10.96
Enterprise Value/EBITDA -4.02
Overview
Shares outstanding 19.14M
Float 16.61M
Shares short -
% Held by insiders 0.2%
% Held by institutions 0.1%
Average volume (10 days) 118.53K
Average volume (90 days) 148.78K
Price summary
52-Week low 200
52-Week high 512
Beta 0.23
50-Day moving average 431.35
200-Day moving average 386
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 100:1
Last split Date 26 Dec 2013
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin -2.96%
Operating margin -2.71%
Operational effectiveness
Return on assets -1.22%
Return on equity -14.32%
Income Statement
Revenue (ttm) 618.65M
Revenue per share (ttm) 36.48
Quarterly revenue growth (yoy) 0.28%
Gross profit (ttm) 418.2M
EBITDA -2.04B
Net income to common (ttm) -2.18B
Diluted EPS (ttm) -107.82
Quarterly earnings growth (yoy) -0.51%
Balance Sheet
Total cash (mrq) 1.48B
Total cash per share (mrq) 55.05
Total debt (mrq) 2.2B
Total Debt/Equity (mrq) -4.87
Current ratio (mrq) 12.08%
Book value per share (mrq) -20.4
Cash Flow
Cash flow statement -2.16B
Levered free cash flow (LFCF) -2.17B
2026 © Marketlog. All Rights Reserved.
